Late Breaking Abstract - Clinical remission with mepolizumab in severe asthma: impact of lung function parameters

被引：1

作者：

Oppenheimer, John ^{[1
]}

Carrillo Diaz, Teresa ^{[2
]}

Martinez Moragon, Eva ^{[3
]}

Sanchez Herrero, M. Guadalupe ^{[4
]}

Banas Conejero, David ^{[4
]}

Chupp, Geoffrey ^{[5
]}

Price, Robert G. ^{[6
]}

Raimondi, Alejandro ^{[7
]}

Zhang, Shiyuan ^{[8
]}

Howarth, Peter ^{[9
]}

Domingo Ribas, Christian ^{[10
]}

机构：

[1] Rutgers New Jersey Med Sch, Newark, NJ USA

[2] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain

[3] Hosp Univ Dr Peset, Valencia, Spain

[4] GSK, Madrid, Spain

[5] Yale Sch Med, New Haven, CT USA

[6] GSK, Stevenage, Herts, England

[7] GSK, Buenos Aires, DF, Argentina

[8] GSK, Collegeville, PA USA

[9] GSK, Brentford, England

[10] Univ Autonoma Barcelona, Barcelona, Spain

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA646

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA646

引用

页数：3

共 50 条

[1] Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab
Almeida, Paula Cristina Andrade
Martin, Matthew J.
Wilkinson, Tina
Hearson, Glenn
Harrison, Tim W.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[2] Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma
Przybyszowski, Marek
Gross-Sondej, Iwona
Zarychta, Jacek
Bazan-Socha, Stanislawa
Bochenek, Grazyna
Soja, Jerzy
Sladek, Krzysztof
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[3] LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma
Almeida, Paula C. A.
Ponte, Eduardo V.
Biao, Valmar
Souza-Machado, Adelmir
Cruz, Alvaro A.
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[4] Late Breaking Abstract - Role of eosinophil mitochondrial function in severe eosinophilic asthma
Koranteng, Janice
Raby, Katie
Dixey, Piers
Lai, Sook Ling
Howarth, Peter
Chung, Kian Fan
Michaeloudes, Charalambos
Bhavsar, Pankaj
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[5] Late Breaking Abstract- Clinical remission with dupilumab in children with uncontrolled, moderate-to-severe, type 2 asthma
Bacharier, Leonard
Guilbert, Theresa W.
Maspero, Jorge F.
Gappa, Monika
Dell, Sharon
Altincatal, Arman
Ledanois, Olivier
Gall, Rebecca
Sacks, Harry
Jacob-Nara, Juby A.
Deniz, Yamo
Rowe, Paul J.
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[6] Late -breaking abstract: Surfact dysregulated in severe asthma
Mackay, Rose-Marie
Grainge, Christopher
Lau, Laurie
Barber, Clair
Clark, Howard
Howarth, Peter
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[7] Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Van Hulst, Glenn
Jorssen, Joseph
Jacobs, Nathalie
Henket, Monique
Louis, Renaud
Schleich, Florence
Bureau, Fabrice
Desmet, Christophe
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[8] Late Breaking Abstract - Asthma control in preschool and subsequent disease remission
Longo, Cristina
Blais, Lucie
Brownell, Marni
Quail, Jaqueline
Sadatsafavi, Mohsen
Forget, Amelie
Li, Wenbin
Tavakoli, Hamid
Tan, Angela
Platt, Robert W.
Ducharme, Francine M.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[9] Late Breaking Abstract - Maternal asthma, weight gain in early life and infant lung function
Belinelo, Patricia De Gouveia
Jesson, Kathryn
Appenzeller, Rhea
Gorlanova, Olga
Collison, Adam
Oldmeadow, Christopher
Murphy, Vanessa E.
Robinson, Paul D.
Latzin, Philipp
Gibson, Peter
Frey, Urs
Mattes, Joerg
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[10] Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma
Hamada, Yuto
Gibson, Peter G.
Harvey, Erin S.
Stevens, Sean
Lewthwaite, Hayley
Fricker, Michael
Mcdonald, Vanessa M.
Gillman, Andrew
Hew, Mark
Kritikos, Vicky
Upham, John W.
Thomas, Dennis
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02):

← 1 2 3 4 5 →